prescription digital therapeutics

The newly released PDTs, now RESET and RESET-O, deliver a self-directed, 12-week course of cognitive behavioral therapy that incentivizes patients to conform to treatment.

The San Francisco-based company will add Limbix's SparkRx offering to its digital therapeutics portfolio.   

The prescription digital therapeutics company is pursuing a sale of the business or its assets.

The announcement comes just weeks after the company reported it let go of approximately 35% of its workforce.

The company has let go of approximately 35% of its workforce.

Austin Speier, chief strategy officer at Click Therapeutics, discusses the company's expanded partnership with Boehringer Ingelheim.

Some experts assert the legislation is preemptive and may stifle innovation, while others argue it has the potential to improve patient access to meaningful healthcare.

The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."

Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.

The partnership with Zuellig Pharma includes Ensemble, Happify's therapeutic for treating major depressive disorder and generalized anxiety disorder, and a prescription digital therapeutic for chronic insomnia.